Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Myosarcoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Sarcoma
Myosarcoma

Subtype

Myosarcoma

CI-CAN-00001265Explore in graph →

106 active trials1 approved drugs38 evidence items

NCIt: C214801
MeSH: D009217

Overview
Statistics
Survival
Genomics4
Variants & evidence38
Drugs4
Trials325
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 58
Ph III recruiting: 6
Growth YoY: −35%
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

StatusAll Active (any)Completed 140 Recruiting 68 Active Not Recruiting 42 Terminated 31 Unknown 18 Withdrawn 13 Not Yet Recruiting 10 Enrolling By Invitation 1 Suspended 1 No Longer Available 1

PhaseAll Early Phase 1 3 N/A 20 Phase 1 120 Phase 2 166 Phase 3 21 Phase 4 2

No study matches these filters